HEADER TRANSFERASE 09-JUL-14 2MRK TITLE FYN SH2 DOMAIN IN COMPLEX WITH THE NATURAL INHIBITORY PHOSPHOTYROSINE TITLE 2 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE FYN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 149-248; COMPND 5 SYNONYM: PROTO-ONCOGENE SYN, PROTO-ONCOGENE C-FYN, SRC-LIKE KINASE, COMPND 6 SLK, P59-FYN; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: C-TERMINAL TYROSINE-PROTEIN KINASE FYN; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: UNP RESIDUES 528-537; COMPND 13 SYNONYM: PROTO-ONCOGENE SYN, PROTO-ONCOGENE C-FYN, SRC-LIKE KINASE, COMPND 14 SLK, P59-FYN; COMPND 15 EC: 2.7.10.2; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FYN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET15B; SOURCE 9 OTHER_DETAILS: THE SH2 DOMAIN FROM HUMAN P59FYN IS REPRESENTED BY SOURCE 10 RESIDUES 149-248.; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 OTHER_DETAILS: THE NATURAL INHIBITORY PEPTIDE IS A 10-RESIDUE SOURCE 16 PHOSPHOTYROSINE SEGMENT FROM THE C-TERMINAL REGION OF THE FYN SOURCE 17 KINASE. KEYWDS PHOSPHORYLATED PEPTIDE, FYN KINASE, SH2 DOMAIN, SRC KINASE, KEYWDS 2 TRANSFERASE EXPDTA SOLUTION NMR NUMMDL 27 AUTHOR R.HUCULECI,L.BUTS,A.J.LENAERTS,N.VAN NULAND REVDAT 3 14-DEC-16 2MRK 1 JRNL REVDAT 2 26-OCT-16 2MRK 1 JRNL REVDAT 1 15-JUL-15 2MRK 0 JRNL AUTH R.HUCULECI,E.CILIA,A.LYCZEK,L.BUTS,K.HOUBEN,M.A.SEELIGER, JRNL AUTH 2 N.VAN NULAND,T.LENAERTS JRNL TITL DYNAMICALLY COUPLED RESIDUES WITHIN THE SH2 DOMAIN OF FYN JRNL TITL 2 ARE KEY TO UNLOCKING ITS ACTIVITY. JRNL REF STRUCTURE V. 24 1947 2016 JRNL REFN ISSN 0969-2126 JRNL PMID 27692963 JRNL DOI 10.1016/J.STR.2016.08.016 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : HADDOCK, CNS REMARK 3 AUTHORS : ALEXANDRE BONVIN (HADDOCK), BRUNGER, ADAMS, CLORE, REMARK 3 GROS, NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HADDOCK RUNS UNDER CNS REMARK 4 REMARK 4 2MRK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-AUG-14. REMARK 100 THE RCSB ID CODE IS RCSB103967. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.50 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.93 MM [U-99% 13C; U-99% 15N] REMARK 210 PROTEIN_1, 1.2 MM PROTEIN_2, 93% REMARK 210 H2O/7% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : VARIAN NMR SYSTEMS REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, CCPNMR, HADDOCK, CNS REMARK 210 METHOD USED : SIMULATED ANNEALING, SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 27 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH22 ARG A 176 O1P PTR B 4 1.55 REMARK 500 OD2 ASP A 191 HZ1 LYS A 201 1.58 REMARK 500 HH21 ARG A 156 O3P PTR B 4 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 153 58.93 -110.56 REMARK 500 1 ARG A 156 -73.05 -94.85 REMARK 500 1 PRO A 169 -174.77 -65.73 REMARK 500 1 ASP A 198 106.16 -170.46 REMARK 500 1 PRO A 245 -85.93 -72.97 REMARK 500 1 HIS A 247 56.12 -155.30 REMARK 500 2 LYS A 153 63.25 -111.19 REMARK 500 2 ARG A 156 -87.11 -124.12 REMARK 500 2 TRP A 192 -167.36 -122.75 REMARK 500 2 ASP A 198 107.29 -178.67 REMARK 500 2 ALA A 219 89.29 -163.48 REMARK 500 2 PRO A 245 -91.93 -76.09 REMARK 500 2 GLN B 5 120.65 -172.86 REMARK 500 3 LYS A 153 58.18 -116.07 REMARK 500 3 ARG A 156 -75.32 -117.55 REMARK 500 3 SER A 165 -73.90 -75.09 REMARK 500 3 ASP A 198 104.85 -165.11 REMARK 500 3 ALA A 219 100.71 -164.42 REMARK 500 3 VAL A 243 76.91 -114.68 REMARK 500 3 PRO A 245 -72.36 -76.65 REMARK 500 3 PRO B 6 -91.63 -69.12 REMARK 500 4 LYS A 153 72.25 -113.25 REMARK 500 4 ARG A 156 -85.56 -125.05 REMARK 500 4 PRO A 169 -177.03 -67.91 REMARK 500 4 ARG A 176 -155.58 -152.94 REMARK 500 4 TRP A 192 -167.87 -129.43 REMARK 500 4 ASP A 198 102.85 -172.64 REMARK 500 4 PRO A 245 -86.46 -73.74 REMARK 500 4 CYS A 246 136.25 179.85 REMARK 500 4 ASN B 9 137.12 -173.25 REMARK 500 5 ARG A 156 -67.98 -95.66 REMARK 500 5 PRO A 169 -175.43 -66.34 REMARK 500 5 ARG A 176 -156.11 -148.51 REMARK 500 5 TRP A 192 -165.56 -128.16 REMARK 500 5 ASP A 198 104.74 -179.41 REMARK 500 5 PRO A 245 -78.89 -72.39 REMARK 500 5 CYS A 246 148.35 -173.51 REMARK 500 5 ASN B 9 -54.54 -148.46 REMARK 500 6 ARG A 156 -76.16 -109.99 REMARK 500 6 PRO A 169 -168.96 -79.25 REMARK 500 6 TRP A 192 -168.75 -120.73 REMARK 500 6 ASP A 198 107.02 178.37 REMARK 500 6 VAL A 243 53.58 -109.02 REMARK 500 6 PRO A 245 -91.64 -78.27 REMARK 500 6 CYS A 246 113.06 -176.39 REMARK 500 6 PTR B 4 35.86 -77.05 REMARK 500 7 ARG A 156 -81.14 -95.26 REMARK 500 7 PRO A 169 -166.78 -72.41 REMARK 500 7 TRP A 192 -164.61 -122.92 REMARK 500 7 ASP A 198 98.56 -178.00 REMARK 500 REMARK 500 THIS ENTRY HAS 198 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17368 RELATED DB: BMRB REMARK 900 FYN SH2 FREE STATE REMARK 900 RELATED ID: 2MQI RELATED DB: PDB REMARK 900 FYN SH2 FREE STATE REMARK 900 RELATED ID: 17369 RELATED DB: BMRB REMARK 900 FYN SH2 IN COMPLEX WITH THE HIGH AFFINITY INHIBITORY PEPTIDE REMARK 900 RELATED ID: 25081 RELATED DB: BMRB REMARK 900 FYN SH2 DOMAIN BOUND TO THE NATURAL INHIBITORY PEPTIDE REMARK 900 RELATED ID: 2MRJ RELATED DB: PDB REMARK 900 FYN SH2 DOMAIN BOUND TO THE NATURAL INHIBITORY PEPTIDE REMARK 900 RELATED ID: 25082 RELATED DB: BMRB DBREF 2MRK A 149 248 UNP P06241 FYN_HUMAN 149 248 DBREF 2MRK B 1 10 UNP P06241 FYN_HUMAN 528 537 SEQRES 1 A 100 TRP TYR PHE GLY LYS LEU GLY ARG LYS ASP ALA GLU ARG SEQRES 2 A 100 GLN LEU LEU SER PHE GLY ASN PRO ARG GLY THR PHE LEU SEQRES 3 A 100 ILE ARG GLU SER GLU THR THR LYS GLY ALA TYR SER LEU SEQRES 4 A 100 SER ILE ARG ASP TRP ASP ASP MET LYS GLY ASP HIS VAL SEQRES 5 A 100 LYS HIS TYR LYS ILE ARG LYS LEU ASP ASN GLY GLY TYR SEQRES 6 A 100 TYR ILE THR THR ARG ALA GLN PHE GLU THR LEU GLN GLN SEQRES 7 A 100 LEU VAL GLN HIS TYR SER GLU ARG ALA ALA GLY LEU CYS SEQRES 8 A 100 CYS ARG LEU VAL VAL PRO CYS HIS LYS SEQRES 1 B 10 GLU PRO GLN PTR GLN PRO GLY GLU ASN LEU MODRES 2MRK PTR B 4 TYR O-PHOSPHOTYROSINE HET PTR B 4 24 HETNAM PTR O-PHOSPHOTYROSINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 2 PTR C9 H12 N O6 P HELIX 1 1 ARG A 156 LEU A 163 1 8 HELIX 2 2 THR A 223 SER A 232 1 10 SHEET 1 A 3 PHE A 173 LEU A 174 0 SHEET 2 A 3 SER A 186 ILE A 189 -1 O SER A 188 N LEU A 174 SHEET 3 A 3 LYS A 201 LYS A 204 -1 O LYS A 201 N ILE A 189 SHEET 1 B 3 ARG A 206 LEU A 208 0 SHEET 2 B 3 GLY A 212 THR A 216 -1 O GLY A 212 N LEU A 208 SHEET 3 B 3 ALA A 219 PHE A 221 -1 O PHE A 221 N TYR A 213 LINK C GLN B 3 N PTR B 4 1555 1555 1.31 LINK C PTR B 4 N GLN B 5 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1